Recently genomics have made unprecedented inroads into cancer diagnostics. With the cost of DNA/RNA sequencing coming down significantly in the last few years and the next-generation-sequencing (NGS) bringing speed, accuracy & reliability, we are certainly in the SCIENTIFIC BREAKTHROUGH ERA! Scientists are developing "DNA/RNA CHIPS" or some Biotechs are already in beta-testing for diagnostics/prognostics/drug discovery kits, which intend to reduce timelines and will be less resource-intensive. These kits are now on the move from LAB-TO-CLINIC-TO-OR (Operating room)......We are witnessing a REVOLUTION IN PERSONALIZED MEDICINE, where ultimate beneficiary will be THE PATIENT! Obviously, in the right scenario, TARGETED THERAPY for the SPECIFIC STAGE(S) OF TUMOR DEVELOPMENT, instead of relying primarily on PHENOTYPIC PATHOLOGY? In addition, portable instruments reading RNA/DNA CHIPS will provide accurate diagnostics at POINT-OF-CARE and hopefully, will make the life of pathologist/oncologist/physician/scientist less stressful......Your thoughts-please.